Design Decisions: A flow of space and light
Profile: Seniors' intimacy expert
By Eleanor Feldman Barbera
by Jackie Vance
By Shelly Mesure
GlaxoSmithKline will pay a $90 million settlement to 38 states that claimed it unlawfully promoted its diabetes treatment Avandia (rosiglitazone). The attorneys general of several states confirmed the action on Thursday.